Creatine Kinase (CK, CK MB) in Blood, Serum, or Plasma

{
  "description" : "This value set may undergo changes until the HL7 Multiple Chronic Care FHIR IG is formally published in 2024.",
  "compose" : {
    "exclude" : [ ],
    "include" : [ {
      "system" : "http://loinc.org",
      "extension" : [ {
        "extension" : [ {
          "valueString" : "concept",
          "url" : "path"
        }, {
          "url" : "count",
          "valueInteger" : 1
        } ],
        "url" : "http://health-samurai.io/extensions/excised-data"
      } ]
    } ]
  },
  "date" : "2022-11-10T01:02:52-05:00",
  "meta" : {
    "versionId" : "7",
    "lastUpdated" : "2022-11-10T01:02:52.000-05:00",
    "profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
  },
  "publisher" : "HL7 Patient Care WG Steward",
  "jurisdiction" : [ {
    "extension" : [ {
      "valueString" : "UNKNOWN",
      "url" : "http://hl7.org/fhir/StructureDefinition/data-absent-reason"
    } ]
  } ],
  "purpose" : "(Clinical Focus: This set of values contains laboratory observable panel code(s) for Creatine Kinase (CK, CK-MB).),(Data Element Scope: The intent of this data element is to identify patients with a lab test performed on a source of blood, serum, or plasma for Creatine Kinase (CK, CK-MB).),(Inclusion Criteria: Creatine Kinase (CK, CK-MB) lab test, using the source of blood, serum, or plasma coded in LOINC, using panel codes. LOINC will need to be referenced for the individual laboratory observations associated with these panel codes.),(Exclusion Criteria: Does not include any codes or concepts which do not represent Creatine Kinase (CK, CK-MB) as defined in the inclusion criteria.)",
  "name" : "CreatineKinaseCKCKMBInBloodSerumOrPlasma",
  "experimental" : false,
  "resourceType" : "ValueSet",
  "expansion" : {
    "contains" : [ {
      "system" : "http://loinc.org",
      "code" : "24335-2",
      "display" : "Creatine kinase panel - Serum or Plasma",
      "version" : "2.74"
    } ],
    "offset" : 0,
    "total" : 1,
    "identifier" : "urn:uuid:8edcda68-2c55-4193-81a8-da5abbdb42f3",
    "timestamp" : "2023-06-29T16:50:05-04:00",
    "parameter" : [ {
      "name" : "count",
      "valueInteger" : 1000
    }, {
      "name" : "offset",
      "valueInteger" : 0
    } ]
  },
  "title" : "Creatine Kinase (CK, CK MB) in Blood, Serum, or Plasma",
  "extension" : [ {
    "valueString" : "MCC eCare Plan Author",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
  }, {
    "valueString" : "MCC_IG",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-keyWord"
  }, {
    "valueDate" : "2022-12-15",
    "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
  }, {
    "valueDate" : "2022-11-10",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
  }, {
    "url" : "http://health-samurai.io/extensions/source",
    "valueCode" : "db"
  } ],
  "status" : "active",
  "id" : "d8bf1206-4d96-4122-9033-32fdbf7f69ee",
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.1579",
  "identifier" : [ {
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113762.1.4.1222.1579"
  } ],
  "version" : "20221110"
}